most adverse effects of trihexyphenidyl
active ingredient
artane
extensions
pharmacologic activity
nature
patients experience
minor side effects
dry mouth
nausea
vision
dizziness
nervousness
elderly patients
underlying
underlying organic brain disease
central effects
gastrointestinal side effects
dry mouth
difficulty
anorexia
constipation
nausea
vomiting
reduction in dosage
problems
paralytic ileus
patients on concomitant phenothiazine
tricyclic antidepressant therapy
withdrawal of medication
nausea
vomiting
cholinergic rebound
bucco-linguo-masticatory dyskinesias
chorea
elderly patients
parkinson
disease with various anticholinergic agents
including trihexyphenidyl
active ingredient
artane
nervous system
side effects
depression
anxiety
listlessness
drowsiness
numbness of fingers
dyskinesia
chorea
higher dosages
> = mg/day
trihexyphenidyl
symptoms of tardive dyskinesia
suppressed symptoms
sleepwalking
drugs
combination of drugs with anticholinergic activity
cognitive deficits
impairment of recent
short-term memory
inability
clinical doses of anticholinergic agents
psychiatric side effects
toxic psychosis
confusion
disorientation
agitation
excitation
memory impairment
delusions
hallucinations
therapeutic dosages
elderly patients
psychiatric deterioration
psychotic flare-ups
been reported following withdrawal of therapy
symptoms
delusions
hallucinations
aggression
violent behavior
suicidal tendencies
high dosages
trihexyphenidyl
active ingredient
artane
euphorigenic effects
reason
drug of abuse
toxic psychosis
several days
week
initiating trihexyphenidyl therapy
hours after an acute overdose
onset
months
symptoms
few days after the discontinuation of medication
ocular side effects
blurred vision
mydriasis
cycloplegia
trihexyphenidyl
active ingredient
artane
angle-closure glaucoma
blindness
cardiovascular
side effects
tachycardia
isolated case of bradycardia
orthostatic hypotension
withdrawal syndromes
following discontinuation of long-term trihexyphenidyl
active ingredient
artane
therapy
genitourinary side effects
urinary retention
dysuria
metabolic side effects
alterations in thermal homeostasis as a result of trihexyphenidyl
active ingredient
artane
inhibition of the body
sweating mechanism
heat stroke
hyperthermia
fever
anticholinergic agents
patients on concomitant neuroleptic
tricyclic antidepressant therapy
anticholinergic poisoning syndrome
week
duration
following trihexyphenidyl
active ingredient
artane
overdose
most patients with anticholinergic intoxication
supportive therapy of vital functions
discontinuation of medications
comatose patients
physostigmine salicylate
acetylcholinesterase inhibitor
peripheral effects
anticholinergic intoxication
peripheral symptoms
addition
dry skin
ekg abnormalities
insomnia
twitching
jerking movements
pantomime activity with nonexistent objects
hyperactivity
hyperreflexia
respiratory arrest
delirium
convulsions
shock
coma
stomach cramps
pain
bloating
constipation
delusions of persecution
mistrust
suspiciousness
combativeness
excessive dryness of the mouth
false beliefs
facts
loss of appetite
nausea or vomiting
seeing
hearing
feeling things
skin rash
stomach pain
tender lymph glands on the side of the face
neck
anxiety
blurred vision
change in vision
decrease in frequency of urination
decrease in urine volume
difficult urination
difficulty
passing urine
dribbling
disturbed behavior
dry mouth
enlarged pupils
eye pain
pounding
irregular heartbeat
pulse
hyperventilation
irritability
loss of vision
mental confusion
nervousness
painful urination
restlessness
shaking
shortness of breath
trouble sleeping
dizziness
mild nausea
nervousness
drowsiness
weakness